Results 291 to 300 of about 725,613 (387)

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.

European Heart Journal, 2013
A. Jørgensen, R. Frikke-Schmidt, A. West, P. Grande, B. Nordestgaard, A. Tybjærg-Hansen   +5 more
semanticscholar   +1 more source

Dietary supplement of sodium butyrate improves the growth performance and intestinal health by targeting Wnt/β‐catenin signaling pathway in rabbits

Animal Research and One Health, EarlyView.
Dietary supplement of sodium butyrate, may relate to regulating intestinal health and thus the growth performance and meat quality of rabbits by regulating the continuous process of promoting the periodic cycle of cecal epithelial cells. Abstract Supplementation of sodium butyrate (SB) has been proved to be beneficial for improving the growth ...
Mengke Ni, Zhitong Wang, Zhichao Li, Mengjuan Chen, Hui He, Hanfang Cai, Zhi Chen, Ming Li, Huifen Xu   +8 more
wiley   +1 more source

The causal association between hyperlipidemia and Alzheimer disease: A combined NHANES and Mendelian randomization study. [PDF]

Medicine (Baltimore)
Sun R, Liu Y.
europepmc   +1 more source

An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

Science, 2001
L. Pennacchio, M. Olivier, J. Hubacek, Jonathan C. Cohen, D. Cox, J. Fruchart, R. Krauss, E. Rubin   +7 more
semanticscholar   +1 more source

Specificity of Milk Lipase for a Butyryl Triglyceride

, 1964
R.G. Jensen, J. Sampugna, Rui Pereira, Ramesh C. Chandan, K.M. Shahani   +4 more
openalex   +1 more source

Impact of Interleukin‐1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the applicability of the 2016 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR)/Paediatric Rheumatology International Trials Organisation (PRINTO) macrophage activation syndrome (MAS) classification criteria in patients with Still disease and systemic juvenile idiopathic arthritis ...
Remco G. A. Erkens, Greta Rogani, Laura Huber, Anouk Verwoerd, Dieneke Schonenberg‐Meinema, J. Merlijn van den Berg, Wineke Armbrust, G. Elizabeth Legger, Sylvia Kamphuis, Ellen J. H. Schatorjé, Esther P. A. H. Hoppenreijs, Joost F. Swart, Marc H. A. Jansen, Jorg van Loosdregt, Sebastiaan J. Vastert   +14 more
wiley   +1 more source

Successful Rituximab Treatment of GPIHBP1 Autoantibody-Associated Hypertriglyceridemia. [PDF]

JACC Case Rep
Hussain T, Horomanski A, Jain S, Lamendola C, Abbasi F, Murakami M, Knowles JW.   +6 more
europepmc   +1 more source

Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.

Clinical Chemistry, 2014
M. Thomsen, A. Varbo, A. Tybjærg-Hansen, B. Nordestgaard   +3 more
semanticscholar   +1 more source

Improving responsiveness of health systems to non-communicable diseases.

, 2013
Atun, Rifat, Banatvala, Nicholas, Barreto, Mauricio L, Jaffar, Shabbar, Knaul, Felicia M, Nishtar, Sania, Nyirenda, Moffat, Piot, Peter   +7 more
core   +1 more source

The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients with Eosinophilic Granulomatosis with Polyangiitis

Arthritis &Rheumatology, Accepted Article.
Objective The Phase 3 MANDARA study demonstrated non‐inferiority of benralizumab versus mepolizumab for remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA). More benralizumab‐treated patients achieved complete withdrawal of oral glucocorticoids (OGCs).
Parameswaran K. Nair, Bernhard Hellmich, Arnaud Bourdin, David R. W. Jayne, Florence Roufosse, Nader Khalidi, Lena Börjesson Sjö, Ying Fan, Christopher McCrae, Sofia Necander, Eva Rodríguez‐Suárez, Anat Shavit, Claire Walton, Peter A. Merkel, Michael E. Wechsler   +14 more
wiley   +1 more source